Search for: "Bristol Meyers Squibb Company"
Results 1 - 20
of 37
Sorted by Relevance
|
Sort by Date
30 Jul 2004, 1:33 pm
Bristol-Meyers Squibb, the leading US AIDs drugs manufacturer, agreed Friday to settle for $300 million shareholder lawsuits alleging that the company inflated its sales by more than $2 billion from 1999 to 2001. [read post]
18 Aug 2021, 12:07 pm
California Attorney General Rob Bonta today announced a $75 million nationwide settlement with global pharmaceutical company Bristol Myers Squibb (BMS), resolving allegations that BMS underpaid the drug rebates owed to Medi-Cal and other state Medicaid programs. [read post]
30 Oct 2020, 11:05 am
Bristol Meyers Squibb appealed. [read post]
20 Jun 2020, 8:38 pm
.; Eldora Ellison of Sterne, Kessler, Goldstein & Fox, PLLC; Serena Farquharson-Torres of Bristol-Meyers Squibb Company; and Joel Stern of the National Association of Minority and Women Owned Law Firms, Inc. will discuss the Practical Guide to D&I in the legal profession and reflect on how to improve diversity and inclusion. [read post]
21 Aug 2013, 9:05 am
Also in Spring 2013, BDR Pharmaceuticals, Ltd. filed the 2nd Indian application for a CL (still pending) for Dasatinib, Bristol Meyers Squibb’s blockbuster anti-cancer drug. [read post]
19 Oct 2010, 8:06 am
., dismissed one set of codefendants (related to Bristol-Meyers Squibb, or BMS), but found the relator’s complaint against AstraZeneca to be sufficiently particular under Rule 9(b). [read post]
12 Apr 2016, 10:57 am
Nicholas Meyer recently filed against Bristol-Myers Squibb and Otsuka Pharmaceutical Co. in the U.S. [read post]
8 Mar 2016, 8:01 am
Nicholas Meyer recently filed against Bristol-Myers Squibb and Otsuka Pharmaceutical Co. in the U.S. [read post]
31 Jan 2015, 8:47 pm
The issue of what, exactly, is ‘implicitly’ disclosed in a prior art reference arises in a decision of a full bench of the Federal Court issued on 23 January 2015 (Bristol-Myers Squibb Company v Apotex Pty Ltd [2015] FCAFC 2) in an appeal relating to a long-running dispute over the validity of a patent covering the antipsychotic drug aripiprazole. [read post]
7 Sep 2009, 12:06 pm
Eighteen months after the auction rate securities markets collapsed when Wall Street withdrew its support, companies like Bristol-Myers Squibb Co., Texas Instruments, Corning, and Teva Pharmaceuticals are still suffering from the Wall Street debacle. [read post]
4 Aug 2016, 9:24 am
It is Bristol-Myers Squibb’s top-selling drug; it earned the pharmaceutical company $6.4 billion in 2013. [read post]
16 Sep 2011, 11:02 am
The state has already settled cases with Astra Zeneca, Abbott Laboratories, GlaxoSmithKline, Amgen Inc., Baxter Healthcare Corp., Boehringer Ingelhelm Roxane, and Dey Pharmaceutical and has prevailed at trial against Johnson & Johnson and Bristol-Meyers Squibb. [read post]
18 Nov 2021, 9:19 am
FTC okays changes to Bristol Meyers Squibb divestiture agreement. [read post]
10 Apr 2015, 3:00 am
” Here, the State of West Virginia, by its Attorney General alleged that the defendants Bristol-Meyers Squibb Company, Sanofi-Aventis U.S., LLC, Sanofi U.S. [read post]
26 Feb 2011, 1:36 pm
Gonzalez v Bristol-Meyers Squibb, 2011WL611722, Docket No. [read post]
9 Mar 2011, 11:14 am
Bristol-Meyers Squibb Co., 156 N.J. 455, 463 (1998) (quoting N.J.R.E. 803(b)(4)). [read post]
9 May 2021, 8:09 am
Other defendants named in the case included Bristol-Meyers Squibb, Cyprus Amax Minerals Company, and Whittaker Clark & Daniels. [read post]
29 Jul 2013, 10:05 am
Also in Spring 2013, BDR Pharmaceuticals, Ltd applied for a CL for Bristol Meyers Squibb’s anti-cancer drug Dasatinib. [read post]
25 Jun 2017, 10:42 pm
” Bristol-Meyers Squibb Co. v. [read post]
20 Jan 2016, 8:00 am
Another expensive drug, this one produced by Bristol-Meyers Squibb, is the hepatitis C pill, Daklinza, which costs $63,000 for a 12-week supply. [read post]